Skip to main content
. 2009 May 28;7:38. doi: 10.1186/1479-5876-7-38

Figure 3.

Figure 3

Survival analysis of metastatic GC (M) group in relation to serum HMGB1 levels. The prognosis of subjects in M group who had serum HMGB1 levels above the mean (> 14 ng/mL) was significantly poorer than those in M group with levels below the mean (Kaplan Meier method, Log-rank test, n = 42, p < 0.05).